but they can be deadly, you don't' to just buy one or two stocks, charlie i took a shot on xyz, it is always riskyiest that i mentioned. you cannot wait to see how they do before in a buy them. also, remember, when stocks move, the fundamental and technical rational changes, same argument cannot be made. >> and don't buy names you only know and like. like, i tell you, you can begin there, but, don't say, i didn't buy that because i didn't know that company or i don't like that stuff. i will admit, i have been a little bit tech hefy in the show, to be honest, coming out the gate, i muched huge, quick winner. this is establishing to a certain degree unrealistic expectations. now i get e-mail when a stock is down a buck, no, the company is not going out of, i will admit, live by the sword, dubai the die -- die by the sword. >> and these are things you want to own when market crashes, utilitys and consumer stain els. -- staples, in your long-term portfolio you should have most of these represented, you out perform the market by over weighing some of them, we have been over weighing techno

obligates that is directed towards the public saying hey please contact our public officials to do xyz. that gets to the expertise lobbyist that was addressed it's true we don't have a regime for that right now. so whether it's that's called for or not if the grand jury thinks to some stent it is that makes sense >> any other comments from the commissioners on finding recommendation 10? finding and recommendation 11? i also want some clarification on 11. i don't know if the city attorney actually should talk about the upcoming case i'd like to know why we think it's maybe you want to change that >> sewer deputy director arnold i believe what the staff is proposing in terms of recommendation 11 in the reference for an upcoming superior court case involving the city and the bay whether e-mails sent concerning city business on the officials private e-mail account are subject to the private records act we're monitoring it internally but that'sha

it's natural for a president to say i am i'm signing this because we need xyz but if this person is an issue that is unconstitutional and i will not feel down about it. it's more of a reaction to something that's even worse. >> another question. >> what is the worst crime? >> i am of two minds of that. one is very difficult to have a defense to and prosecutors think if the jury gets used as a guilty they will say it a lot so you want one count that is pretty bulletproof and attorney that would be the failure to execute the law faithfully. even the most ardent admirers would have to concede that he doesn't follow federal law. the main defense they never say that he's executing it faithfully and i laid out numerous instances of his own obamacare law that is the signature legislative accomplishment. i think that he had intended it 36 times. i haven't checked since i've gotten here so i think that one is pretty strong but the one that offends me the most enough to be offensive to the country is the massacre that i don't consider as just something that happened september 11 of 2012. in the

you ask me, is xyz ipo a good one? some it depends on how they bring the deal and it's the gibberish for the amount of shares being offered. there will be 50 million shares outstanding. the bankers are talking about bring the deal at 20 and 1 billion, $20 times 50 million shares, but the bankers can do a lot of different things. first, they don't offer all of the stock well is, venture capitalists that might fund it might own a lot, whoever ceded the company might have substantial shares left. the price that they're talking about, that may just be the price talk. meaning what the initial price they are thinking of bringing the company at, know the last price. if demand accelerates y'all hear the price move up, maybe to 25, maybe to 30. obviously, that values the company in a much more rich level. i may like the ipo if it is valued at 20, and i might like the stock at 20 and think it's a sale of 30. you would accept that with anything other than i'm and some stocks coget too expensive. the bankers, if they want the stoc

at the editorial pages, putin is hitler, this is the cold war, this is the biggest threats since y xyz and the rhetoric is getting in the way of analysis. >> there is no question that russia has to some extend invaded ukraine. >> i don't see how you could argue against that points, of course. >> right. we have heard a lot of noise, wesley clark, former nato commander, i heard him say if russia innervates ukraine, the consequences will be inning calculable. a lot of rhetoric. but hughes does it mean? >> exactly. one of the very distressing trends that we have seen russia did something that two weeks ago seems unmanageable and the most of the west says what are we going to do maybe rachet up some sanctions and then two weeks after that this do something else, and the west keeps trying to play catch up. but the reality remains that there is little that the west can easily do here . one of the things that we are hearing a lot is arming the ukrainian army. and i am not against that, but it doesn't necessarily solve anything. ukrainian military armed with arms from the west, would still have

won't do it because bill gross will have good reasons and i will feel awful i said it's because of xyz. i take him at face value when he says it's mixed blessings. all i know is it isn't you're only as good as your last trade in bond. this man has $2.2 trillion over management. >> he had. now he's going to -- >> janus offers him a deal. he gets to say where he is. >> he gets the newport beach office. janus stock price is up sharply. we know there is a big back story here. this was head as we were heading to air. hard for me to do some reporting, but andrew is off-air in nantucket. he's probably been able to do a little more reporting and can give us insight here. any sense on what the back story is here? >> let me tell you what i do know. i just got off the telephone. i'm going to get rid of this, i have a little bit of back and forth. what i do know is the following. here is the relationship in terms of how bill gross ended up at janus. the ceo of janus is dick weill. dick used to be the coo of pimco. that's the relationship and where it came from. dick weill left pimco because of ano

and without that, arming xyz group won't solve the problem.s just -- >> do you have anything to chime into this? >> no, i wanted to add about the arming of whatever the foreign fighters. people are very much aware, there's not going to be an ideal situation here, okay. and even this weapon, in addition to what they're saying, not only what you should arm or not, if you're going to arm, what's going to be the nature of the weapons and how effective will they be? talking about heavy weapons or training a few thousand soldiers? how effective will it be? and who is -- and where the arms will end up, for what objective. we're still not sure because the objective in syria among several groups -- some of them we want to overthrow assad. while overthrowing assad for some groups is not the same objective as degrading isis in and of itself. and i cannot ascertain. and i don't think anybody can that those weapons being used to push back or degrade isis are not going to be used by those groups against a larger mission. and this is where it's going to get

turnover or leaving of the field by recent college graduates that thought they were going to do thing xyz and find out that the field is really not that. and one of the ways in which you get at that challenge is making sure that those kids -- so the kids most commonly that don't stay within the s.t.e.m. fields either didn't have a person in their family that was involved in that field, they didn't have a mentorship experience along the way, they didn't have an internship. and the next best explanation is usually that they didn't have the type of training in teams, which is how most of the companies work. and those are all things that are very hard -- they're almost impossible to legislate, but they're even harder to get at in a policy context because they're all social skills. and those are not things that we can expect, you know, standards or policies to address directly. but i think the way we address them is by if you really make the s.t.e.m. subjects a priority and we hold the people who run our schools accountable for it, then we'll figure out how to solve those challenges in the sam

issues.ree on abcd issues.ree on xyz why should we indulge on this kind of political vanity and be overwhelmed by what i call the yuck factor. this is what liberals have to theover, the yuck factor, liberal intelligentsia, because they do not feel the need out there, they do not have the empathy. they're too busy writing articles and being in the top 1% or 2% in this country to get over it. they are not affected by this. but millions as millions of people can be a media in one area after another. rigid onals are more all these issues i have found that people who are really conservatives,. corporatists in conservative garb. you can see that in the question of the question of the 2000 campaign. get over it. the democratic party could have blocked which on iraq, from the tax, they succumbed to bush, they could have blocked him. look at what the republicans are doing to obama. get over it. stop's a coding the been party. stop finding an alibi before you're not standing up to the american people and their rights instead of dialing for the same commercial dollars that the republicans do. [applause]

drug, you should request from your pharmacist and he can find it for you, that you get, you know, the xyzuse it may be very different for the next one. 12 different versions of that generic out there. you need to be, as a consumer, on top of this a bit. >> here is what the fda has to say about this. to gain fda approval generic drug must meet rigorous standards. bioequivalent to the brand product meaning that the drug reaches the part of the body that the is intended to treat at the same rate and extent as the brand product. but your study here raises some red flags. >> definitely. >> it is just not always the case. and the fda really needs to be more for the coming about this information about whether things are equivalent or not. when they actually did test this product after it had been on the market for five year. they found that only 40% of the drug level was achieved with the generic in stern people versus the grand name. >> sometimes word spending the extra cash. dr. todd cooperman thank you so much for your time today. >> you are welcome. >> coming up on "fox & friends," the justi